CignaHealth Approves Helius Medical's PoNS Device Claim
Recent Advancement in PoNS Device Authorization
CignaHealth has recently authorized claims for Helius Medical Technologies' Portable Neuromodulation Stimulator (PoNS) Device. This development marks a significant milestone, as CignaHealth is the fifth major payer to approve the PoNS device at an out-of-network adjusted negotiated list price of $19,161. This follows another key authorization by Anthem MultiPlan, which approved the PoNS Device at a similar out-of-network negotiated price of $19,160. These approvals are vital for improving access to innovative treatment options for patients suffering from multiple sclerosis (MS).
Enhancing Patient Access and Value
Dane Andreeff, the President and CEO of Helius, expressed enthusiasm over securing approvals from five major commercial healthcare payers. He highlighted that these out-of-network reimbursements whether actual sales are realized depend on individual patient situations, including deductibles and out-of-pocket expenses. The company is committed to advocating for wider reimbursement from the Centers for Medicare & Medicaid Services (CMS) to expand access even further.
Understanding the PoNS Device
The Portable Neuromodulation Stimulator (PoNS) is a groundbreaking device designed to improve balance and gait in individuals with neurologic deficits, particularly those suffering from MS. This non-invasive therapy utilizes a mouthpiece connected to a controller which delivers neurostimulation through mild electrical impulses to the tongue. The device is specifically indicated for individuals aged 22 and over and is to be used alongside a supervised therapeutic exercise program.
Proven Effectiveness in Treatment
Studies have demonstrated the effectiveness of the PoNS device not only in improving gait and balance but also in significantly reducing fall risks in stroke patients. In Canada, the device has received approval for treating gait deficits and chronic balance issues stemming from both stroke and mild-to-moderate traumatic brain injuries (mmTBI). In Australia, it is authorized for use by healthcare professionals as an adjunct to therapeutic exercise to enhance balance and gait.
About Helius Medical Technologies
Helius Medical Technologies is an innovative neurotech company specializing in solutions for neurologic deficits. Its flagship product, the PoNS device, stands out in the medical device arena for transforming how individuals with neurologic conditions experience rehabilitation. The technology promotes neuroplasticity, helping to empower the brain's ability to adapt and support functional recovery.
Engaging with Patients and Healthcare Providers
Helius is dedicated to improving the quality of life for those affected by neurologic disease. By closely collaborating with healthcare providers, Helius aims to enhance therapy outcomes through products like the PoNS device. The ongoing clinical data continues to support its effectiveness, ensuring that both patients and their providers have the tools needed for successful rehabilitation.
Investor Engagement
Philip Trip Taylor from Gilmartin Group manages investor relations for Helius Medical Technologies. Interested parties can reach out for further information or inquiries through their contact channels. As the company continues to pursue additional avenues for expansion, stakeholder engagement remains a top priority, ensuring transparency and fostering collaborative opportunities.
Frequently Asked Questions
What is the PoNS Device?
The Portable Neuromodulation Stimulator (PoNS) is a device that delivers neurostimulation through a mouthpiece to help improve balance and gait in patients with neurologic deficits.
How does CignaHealth's authorization impact access to the PoNS Device?
CignaHealth's authorization increases accessibility for MS patients by allowing them to get reimbursed for the cost of the PoNS device, thereby improving treatment options.
What is Helius Medical Technologies' mission?
Helius Medical Technologies aims to enhance the lives of individuals with neurologic conditions by providing innovative solutions that promote neuroplasticity and improve functional recovery.
Can the PoNS Device be used for other conditions?
Yes, besides MS, the PoNS Device is also effective for treating gait deficits and balance issues linked to mild-to-moderate traumatic brain injuries and stroke in certain regions where it is authorized.
Where can I learn more about the PoNS Device?
For additional information about the PoNS device and Helius Medical Technologies, you can visit their official website.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
